February 21, 2011

Genovis AB nomination committee appointed

Regulatory

As decided by the 2010 Annual General Meeting (AGM), a nomination committee has been appointed composed of:

Bo Håkansson

Torbjörn Fridh

Sarah Fredriksson

René in ‘t Zandt

The nomination committee represents 30% of the total number of votes in the company.

The AGM will be held on April 28, 2011 at 5:00 PM in Genovis facilities at Scheelevägen 22 in Lund, Sweden.

For more information, please contact: Sarah Fredriksson, CEO, Genovis AB Tel: 46 46 10 12 35 sarah.fredriksson@genovis.com

Genovis is a biotech company on the leading edge of nanotechnology and nanoparticles. The company’s patented nano-induced magnetic transfer (NIMT®) technology was developed to facilitate effective preclinical research for the life science industry. Genovis shares are listed on Nasdaq OMX First North and Thenberg & Kinde Fondkommission is our certified adviser.

wkr0001.pdf
  • Svenska